DK480685D0 - Dna-sekvenser, rekombinant-dna samt fremgangsmaader til fremstilling af antigener af plasmodium falciparum - Google Patents

Dna-sekvenser, rekombinant-dna samt fremgangsmaader til fremstilling af antigener af plasmodium falciparum

Info

Publication number
DK480685D0
DK480685D0 DK480685A DK480685A DK480685D0 DK 480685 D0 DK480685 D0 DK 480685D0 DK 480685 A DK480685 A DK 480685A DK 480685 A DK480685 A DK 480685A DK 480685 D0 DK480685 D0 DK 480685D0
Authority
DK
Denmark
Prior art keywords
procedures
preparation
plasmodium falciparum
dna
falciparum antigens
Prior art date
Application number
DK480685A
Other languages
Danish (da)
English (en)
Other versions
DK480685A (da
Inventor
Bernard Mach
Luc Perrin
Michael Mc Garvey
Andrew Cheung
Alan Shaw
Original Assignee
Biogen Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10556870&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK480685(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biogen Nv filed Critical Biogen Nv
Publication of DK480685A publication Critical patent/DK480685A/da
Publication of DK480685D0 publication Critical patent/DK480685D0/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/6893—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK480685A 1984-02-20 1985-10-18 Dna-sekvenser, rekombinant-dna samt fremgangsmaader til fremstilling af antigener af plasmodium falciparum DK480685D0 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848404378A GB8404378D0 (en) 1984-02-20 1984-02-20 Dna sequence recombinant dna molecules
PCT/GB1985/000072 WO1985003725A1 (en) 1984-02-20 1985-02-20 Dna sequences, recombinant dna and processes for producing antigens of plasmodium falciparum

Publications (2)

Publication Number Publication Date
DK480685A DK480685A (da) 1985-10-18
DK480685D0 true DK480685D0 (da) 1985-10-18

Family

ID=10556870

Family Applications (1)

Application Number Title Priority Date Filing Date
DK480685A DK480685D0 (da) 1984-02-20 1985-10-18 Dna-sekvenser, rekombinant-dna samt fremgangsmaader til fremstilling af antigener af plasmodium falciparum

Country Status (8)

Country Link
EP (1) EP0172865B2 (ja)
JP (1) JPS61501547A (ja)
AU (2) AU3995985A (ja)
DE (1) DE3582203D1 (ja)
DK (1) DK480685D0 (ja)
GB (1) GB8404378D0 (ja)
WO (1) WO1985003725A1 (ja)
ZA (1) ZA851305B (ja)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2145092B (en) * 1983-01-28 1988-04-07 Univ New York Protective peptide antigen
DK79985A (da) * 1984-02-22 1985-08-23 Wellcome Found Kloning af dna for protozoelle antigener og dets anvendelse
IL76338A (en) * 1984-09-11 1994-08-26 Saramane Pty Ltd Plasmodium plasmodium immunogenic polypeptides, AND molecules encoding them, a method for preparing the polypeptides and preparations containing the polypeptide
IL78476A0 (en) * 1985-04-11 1986-08-31 Inst Medical W & E Hall Highly repetitive antigens of plasmodium falciparum
US5866363A (en) * 1985-08-28 1999-02-02 Pieczenik; George Method and means for sorting and identifying biological information
IL79881A (en) * 1985-08-28 1995-12-08 Pieczenik George Populations of random coding series of oligonucleotides and peptides
EP0254862A1 (en) * 1986-06-26 1988-02-03 BEHRINGWERKE Aktiengesellschaft Vaccines against protozoan parasites
AU594804B2 (en) * 1986-07-17 1990-03-15 Saramane Pty Ltd Small molecular weight antigen of plasmodium falciparum
EP0273971A4 (en) * 1986-07-17 1989-09-19 Saramane Pty Ltd ANTIGEN OF -i (PLASMODIUM) -i (FALCIPARUM) HAVING LOW MOLECULAR WEIGHT.
AU595056B2 (en) * 1986-07-17 1990-03-22 Program For Appropriate Technology In Health (Path) Merozoite surface antigen of plasmodium falciparum
DE3741057A1 (de) * 1987-03-18 1988-09-29 Behringwerke Ag Klonierung von malaria-spezifischen dna-sequenzen:isolierung des gens fuer das 140 kd protein
ZA888983B (en) * 1987-12-01 1989-08-30 Saramane Pty Ltd Rhoptry antigen of plasmodium falciparum
AU625713B2 (en) * 1988-02-19 1992-07-16 Microgenesys, Inc. Method for producing recombinant protein derived from the circumsporozoite gene of plasmodium falciparum
US5231168A (en) * 1988-09-16 1993-07-27 Statens Seruminstitut Malaria antigen
SE8904100D0 (sv) * 1989-12-05 1989-12-05 Astra Ab New analysis method
ES2044749B1 (es) * 1991-06-12 1994-07-16 Consejo Superior Investigacion Procedimiento para la deteccion y diagnostico de infecciones por organismos patogenos.

Also Published As

Publication number Publication date
GB8404378D0 (en) 1984-03-28
WO1985003725A1 (en) 1985-08-29
AU3995985A (en) 1985-09-10
JPS61501547A (ja) 1986-07-31
EP0172865B1 (en) 1991-03-20
EP0172865A1 (en) 1986-03-05
DE3582203D1 (de) 1991-04-25
AU5112990A (en) 1990-11-08
DK480685A (da) 1985-10-18
ZA851305B (en) 1986-03-26
EP0172865B2 (en) 1994-06-01

Similar Documents

Publication Publication Date Title
DK480685A (da) Dna-sekvenser, rekombinant-dna samt fremgangsmaader til fremstilling af antigener af plasmodium falciparum
DK110885A (da) Nucleinsyre-proteinkonjugater, disses anvendelse samt fremgangsmaade til fremstilling heraf
FR2621487B1 (fr) Virus avipox recombinant
DK425885D0 (da) Antistof, fremgangsmaade til fremstilling heraf samt anvendelse vedpaavisning af oncogene produkter
ZA853026B (en) Leukemia-associated virus immunogen,vaccine and assay
DK54184A (da) Dna-sekvenser, rekombinations-dna-molekyler samt fremgangsmaader til fremstilling af human (interleukin) to-lignende polypeptider
IT8522564A0 (it) Procedimento per la preparazione di idroalofluoroalcani.
IT8421622A0 (it) Procedimento per la preparazione di peptidi.
ATE78869T1 (de) Malaria-impfstoff.
ATE82322T1 (de) Malaria-impfstoff.
DK661288A (da) Iminophenylthiazolidiner, fremgangsmaade til deres fremstilling samt anvendelsen heraf
DK271588D0 (da) Genteknologisk fremgangsmaade til fremstilling af angiogeniner
DK418386A (da) Kombinationspraeparat til behandling af malaria
KR880700074A (ko) 위광견병 비루스 단백질
DK603987A (da) Fremgangsmaade til fremstilling af purin-9-ylalkylenoxymethylphosphonsyrer
DK106589A (da) Fremgangsmaade til fremstilling af aenaturligtae methylanthranilat
DK540887D0 (da) Iminooxazolidiner, fremgangsmaade til deres fremstilling samt anvendelse deraf
DK82387A (da) Fremgagsmaade til fremstilling af cyanidhydratase
EP0217877A4 (en) VERY REPEATABLE ANTIGENS FROM PLASMODIUM FALCIPARUM.
ATE61818T1 (de) Dns-sequenzen, rekombinante dns und verfahren zur herstellung von plasmodium-falciparumantigenen.
DK47387A (da) Acylerede sulfonylquanidiner, fremstilling og anvendelse deraf, samt mellemprodukter til deres fremstilling og fremstilling af disse
DK490587D0 (da) Genteknisk fremgangsmaade til fremstilling af lakse-calcitonin samt middel til gennemfoerelse af fremgangsmaaden
NZ215820A (en) Hepatitis b antigen formed by recombinant dna techniques
DE3751933D1 (de) Merozoit-oberflächen-plasmodium-falciparum-antigen
DK688287A (da) Poroes saarforbinding samt fremgangsmaade til fremstilling af denne

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment